AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Zuvitroz 2.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Zuvius Life Sciences

Salt Composition

Letrozole (2.5mg)

Overview Zuvitroz 2.5mg Tablet

Post-menopausal women with breast cancer may find relief with Zuvitroz 2.5mg Tablets. This medication can be used independently or alongside other therapies like surgery or radiotherapy. In advanced cases, it helps control the cancer's spread. Zuvitroz 2.5mg Tablets may be taken with or without food, always adhering to your doctor's prescribed dosage and duration for optimal results. Dosage frequency is tailored to individual needs and determined by your physician to effectively manage your symptoms. Continuous use, as directed, is crucial. Common side effects include hot flushes, tiredness, increased perspiration, and elevated cholesterol (hypercholesterolemia). Report any concerning side effects to your doctor, who can offer management strategies. Prior to commencing treatment, inform your doctor about any pre-existing liver or kidney conditions, or a history of osteoporosis. Complete disclosure of all other medications is essential, as interactions can affect Zuvitroz's efficacy. Furthermore, disclose any pregnancy or breastfeeding status. Your doctor may order blood tests to monitor vitamin D levels and bone density throughout your treatment.

Uses of Zuvitroz 2.5mg Tablet

Managing breast cancer

Major Benefits of Zuvitroz 2.5mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 2.5mg Zuvitroz tablet whole; do not damage it by chewing, crushing, or breaking. While this medication can be taken with or without food, consistent timing is recommended.

Common Side effects of Zuvitroz 2.5mg Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Zuvitroz 2.5mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Zuvitroz 2.5mg Tablets can be consumed with or without food, although consistent timing is recommended.

How Zuvitroz 2.5mg Tablet works:

Estrogen production is reduced by the aromatase inhibitor Zuvitroz 2.5mg Tablet. This lowered estrogen level inhibits the growth of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse interactions between Zuvitroz 2.5mg Tablet and alcohol consumption.

PregnancyPregnancyUNSAFE

Pregnant individuals should absolutely avoid Zuvitroz 2.5mg Tablets. Research in animal and human studies demonstrates substantial risks to fetal development; consult a physician before use.

Breast feedingBreast feedingUNSAFE

Lactation and the use of Zuvitroz 2.5mg tablets are incompatible due to potential infant toxicity indicated by available data.

DrivingDrivingUNSAFE

Taking a Zuvitroz 2.5mg tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

The 2.5mg Zuvitroz tablet presents a safe treatment option for individuals with kidney disease, requiring no dosage modification. Nevertheless, data on its use in patients experiencing end-stage renal failure remains scarce. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Zuvitroz 2.5mg tablets cautiously; dosage modification may be necessary. Physician consultation is recommended.

What if you forget to take Zuvitroz 2.5mg Tablet :

Should you forget a Zuvitroz 2.5mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Zuvitroz 2.5mg Tablet

LabelValue
Chemical Classification Diphenylmethane-based compound
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Zuvitroz 2.5mg Tablet

Zuvitroz 2.5mg tablets are aromatase inhibitors used to treat breast cancer in postmenopausal women.
Zuvitroz 2.5mg tablets are anti-estrogens. They work by inhibiting aromatase, the enzyme that produces estrogen, thereby lowering estrogen levels. This is beneficial because estrogen fuels the growth of certain breast cancers, known as estrogen-dependent cancers. Lowering estrogen production can help prevent cancer growth.
For advanced breast cancer or cancer that has spread, continue taking Zuvitroz 2.5mg Tablet until tumor progression. Following tamoxifen or surgery, take Zuvitroz 2.5mg Tablet for five years or until recurrence, whichever occurs first. Alternatively, a sequential regimen of two years of Zuvitroz 2.5mg Tablet followed by three years of tamoxifen may be used.
While irbesartan and Zuvitroz 2.5mg Tablet can be taken together, monitor your blood pressure closely as Zuvitroz 2.5mg Tablet may elevate it. Consult your doctor if blood pressure management becomes difficult.
While rare, Zuvitroz 2.5mg Tablets may cause cataracts. Report blurred vision or eye irritation to your doctor promptly.
Experiencing hot flashes may indicate a common side effect of Zuvitroz 2.5mg Tablet, linked to decreased estrogen. These typically lessen as your body adapts, though some individuals may experience them throughout and for a few months after treatment. Consult your doctor if hot flashes are severe.
While rare, Zuvitroz 2.5mg Tablet may cause serious side effects such as stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions.
Taking Zuvitroz 2.5mg tablets can lead to bone thinning (osteoporosis) from reduced estrogen. Your doctor may monitor your bone density before, during, and after treatment to detect osteoporosis.
The Ministry of Health and Family Welfare restricts Zuvitroz 2.5mg Tablets to the induction of ovulation in women with anovulatory infertility.
Zuvitroz 2.5mg Tablet
158